Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of ...

When diabetics and nondiabetics were analyzed together, ACE inhibitors or ARBs were significantly more effective than other antihypertensives in reducing ESRD incidence, serum creatinine levels ...

The Federal Executive Council, FEC, on Wednesday approved about N10.299 billion for the procurement of diagnostic kits for ...

Santo Domingo- The Central Bank reported on Thursday that February’s inflation closed with a slight growth of 0.32%, driven ...

(FEC) on Wednesday approved about N10.299 billion for the procurement of diagnostic kits for diabetes, antiretroviral drugs for resistant ...

The Federal Executive Council on Wednesday, approved about N10.299 billion for the procurement of diagnostic kits for ...

Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

With a potential buyer not working out, Idorsia has adjusted an existing partnership and restructured bonds to raise cash.

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

Aprocitentan is approved as TRYVIO™ in the US for the treatment of systemic hypertension in combination with other antihypertensives and has been commercially available since October 2024.

Lorundrostat is an orally-administered highly selective aldosterone synthase inhibitor that reduces aldosterone levels by inhibiting CYP11B2. The Launch-HTN trial (ClinicalTrials.gov Identifier: ...